Health Condition 1: D75- Other and unspecified diseases ofblood and blood-forming organs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants with primary hypertension and on oral hypotensive drugs with blood pressure above 140/90 mmHg, aged between 30 and 50 years no restrictions on gender or race and willing to participate in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria included a history of surgery within the past year, women who are pregnant, menstruating, or lactating, patients over 50 years old, and those with hypertension associated with systemic complications such as diabetes or obesity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will focus on heart rate variability (HRV) parameters, specifically assessing MeanRR (s), SDNN (ms), RMSSD (ms), pNN50%, LF (n.u), HF (n.u), and LF/HF Ratio. These metrics will be evaluated to determine any changes before and after the administration of Lotus tea in patients with primary hypertension.Timepoint: Baseline and post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressureTimepoint: Baseline: Before the intervention begins. Week 1: Seven days after starting the intervention. Week 2: Fourteen days after starting the intervention. Week 3: Twenty-one days after starting the intervention. Week 4: Twenty-eight days after starting the intervention. Post-intervention: One week after completing the intervention. | — |
Countries
India
Contacts
International institute of yoga and naturopathy medical science